In early October, the Food and Drug Administration (FDA) published a new Transparency Roadmap in an FDA Voices post authored by Lowell M. Zeta, Acting Chief of Staff, that lays out five transparency-related priorities for the agency in fiscal year 2027. The Roadmap not only shares what actions FDA has taken, but some of what is still on the docket for the coming year. See Tiber Creek’s one-pager on the new FDA Transparency Roadmap, here.
